North America Endothelial Dysfunction Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – Regional Analysis – by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)

No. of Pages: 115    |    Report Code: BMIRE00029161    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Endothelial Dysfunction Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Endothelial Dysfunction Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Endothelial Dysfunction Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Incidence of Cardiovascular Diseases Favors the Market Growth
5.2 Market Opportunities
  • 5.2.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies is Likely to Create Opportunities in the Market
5.3 Future Trends
  • 5.3.1 Noninvasive Methods to Assess Endothelial Dysfunction
5.4 Impact of Drivers and Restraints

6. North America Endothelial Dysfunction Market Regional Analysis

6.1 North America Endothelial Dysfunction Market Overview
6.2 North America Endothelial Dysfunction Market Revenue 2020-2028 (US$ Million)
6.3 North America Endothelial Dysfunction Market Forecast Analysis

7. North America Endothelial Dysfunction Market Analysis – by Cause

7.1 Hypertension
  • 7.1.1 Overview
  • 7.1.2 Hypertension: North America Endothelial Dysfunction Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Diabetes
  • 7.2.1 Overview
  • 7.2.2 Diabetes: North America Endothelial Dysfunction Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Hypercholestrolaemia
  • 7.3.1 Overview
  • 7.3.2 Hypercholestrolaemia: North America Endothelial Dysfunction Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Bechet's Disease
  • 7.4.1 Overview
  • 7.4.2 Bechet's Disease: North America Endothelial Dysfunction Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Obesity
  • 7.5.1 Overview
  • 7.5.2 Obesity: North America Endothelial Dysfunction Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Endothelial Dysfunction Market Analysis – by Test Type

8.1 Invasive Tests and Non-Invasive Tests
  • 8.1.1 Overview
  • 8.1.2 Invasive Tests and Non-Invasive Tests: North America Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Endothelial Dysfunction Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Invasive Tests and Non-Invasive Tests: North America Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Ambulatory Surgery Centers
  • 9.2.1 Overview
  • 9.2.2 Invasive Tests and Non-Invasive Tests: North America Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Specialty Clinics
  • 9.3.1 Overview
  • 9.3.2 Invasive Tests and Non-Invasive Tests: North America Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Endothelial Dysfunction Market – North America Analysis

10.1 North America
  • 10.1.1 North America Endothelial Dysfunction Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Endothelial Dysfunction Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Endothelial Dysfunction Market Breakdown, by Cause
    • 10.1.1.1.2 US: North America Endothelial Dysfunction Market Breakdown, by Test Type
    • 10.1.1.1.3 US: North America Endothelial Dysfunction Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Endothelial Dysfunction Market Breakdown, by Cause
    • 10.1.1.2.2 Canada: North America Endothelial Dysfunction Market Breakdown, by Test Type
    • 10.1.1.2.3 Canada: North America Endothelial Dysfunction Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Endothelial Dysfunction Market Breakdown, by Cause
    • 10.1.1.3.2 Mexico : North America Endothelial Dysfunction Market Breakdown, by Test Type
    • 10.1.1.3.3 Mexico : North America Endothelial Dysfunction Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Endothelial Dysfunction Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Endothelix Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Everist Health Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Lawrence Berkeley National Laboratory
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Medizinische Messtechnik GmbH
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Perimed AB
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 SMART Medical Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 ZOLL Medical Corp
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  • Endothelix Inc
  • Everist Health Inc
  • Lawrence Berkeley National Laboratory
  • Medizinische Messtechnik GmbH
  • Perimed AB
  • SMART Medical Ltd
  • ZOLL Medical Corp
north-america-endothelial-dysfunction-market